logo
Onesource Specialty Pharma shares fall nearly 2% following Q1 results

Onesource Specialty Pharma shares fall nearly 2% following Q1 results

Business Upturn17 hours ago
By Aditya Bhagchandani Published on August 5, 2025, 09:22 IST
Shares of Onesource Specialty Pharma fell 1.45% to Rs 1,890 on Tuesday, August 5, amid the release of the company's Q1 FY26 results. The stock opened lower and hit an intraday low of Rs 1,826.10, down from the previous close of Rs 1,917.90. The company's market cap stood at Rs 21,596 crore.
On the earnings front, the company reported a significant improvement in its bottom line. Net loss narrowed sharply to Rs 0.19 crore in the quarter ended June 2025, compared to a loss of Rs 5.55 crore in the same quarter last year. Revenue rose 11.97% to Rs 327.27 crore as against Rs 292.29 crore in Q1 FY25.
Operating profit margin improved to 27.04% from 22.00%, while profit before depreciation, interest and tax (PBDT) surged 153% to Rs 66.27 crore from Rs 26.23 crore a year ago. Loss before tax (PBT) also narrowed to Rs 1.53 crore from Rs 42.12 crore.
The stock has traded in a 52-week range of Rs 1,209.95 to Rs 2,248.00.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Amex GBT Aims for $155 Million in Savings From CWT Merger
Amex GBT Aims for $155 Million in Savings From CWT Merger

Skift

time26 minutes ago

  • Skift

Amex GBT Aims for $155 Million in Savings From CWT Merger

The stock market liked the optimistic story that Amex GBT was telling about the CWT acquisition and margin expansion. Large mergers can be messy affairs, but Global Business Travel Group officials are focused on cost savings now that the merger with CWT is slated to close soon. 'We expect to deliver approximately $155 million in identified net synergies and have a proven track record of integrating large acquisitions and achieving our synergy targets,' Paul Abbott, the CEO of Amex GBT, said during the second-quarter earnings call. Those savings would be over a three-year period. The merger of the #1 (Amex GBT) and #4 (CWT) largest global players in business travel is on track to close before the end of September now that the U.S. Department of Justice dismissed its own lawsuit against the merger. Abbott said that 'given the recent clarity on CWT,' it plans to initiate additional share repurchases in the next few months. The CEO said he can't comment on CWT's financial performance but will do so in November during the next quarterly presentation. 'Our commercial success, margin expansion and improved demand environment give us confidence to raise and narrow our full-year 2025 guidance,' Abbott said. Customer Wins The commercial success was a reference to market share gains and $3.2 billion in new customer wins over the past year. Some $2.2 billion of those wins were of small- and medium-sized businesses, a segment that has been traditionally hard to capture. Amex GBT's adjusted EBITDA increased 4% in the second quarter. Revenue rose 1% to $631 million. After macro uncertainty saw corporate travel demand dip modestly in April, transactions grew a combined 2% in May and June. 'We continue to see green shoots into July that give us confidence that the demand environment has improved,' Abbott said.

Stock Movers: Super Micro, Rivian, Axon
Stock Movers: Super Micro, Rivian, Axon

Bloomberg

time27 minutes ago

  • Bloomberg

Stock Movers: Super Micro, Rivian, Axon

On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Sonali Basak, Carol Massar and Matt Miller. - Super Micro (SMCI) shares dropped after lowering its fiscal year sales forecast, suggesting the company continues to face uneven uptake of powerful AI servers amid a shift to products based on new Nvidia Corp. chips. The company said Tuesday that revenue in the year ending in June 2026 will be at least $33 billion. In February, Super Micro offered a bullish long-term outlook because of demand for AI products, saying sales will be $40 billion — then almost twice as much as analysts' estimates for the current fiscal year. - Rivian (RIVN) forecast a larger adjusted loss this year than the electric vehicle maker expected previously, citing recent changes to stringent fuel economy rules in the US that threaten a key source of revenue. The adjusted loss before interest, taxes, depreciation and amortization this year will be $2 billion to $2.25 billion, the company said Tuesday. It had previously forecast a loss of no more than $1.9 billion by that measure, while Wall Street analysts had expected about $1.8 billion on average. Shares slid in the aftermarket. - Axon (AXON) shares soared in trading today and hit a record intraday high after the maker of Tasers and other public safety equipment reported second-quarter earnings per share that topped expectations. Analysts also noted strong bookings for the company's AI plan.

S&P/TSX composite starts the week on the rise while U.S. markets fall
S&P/TSX composite starts the week on the rise while U.S. markets fall

Yahoo

timean hour ago

  • Yahoo

S&P/TSX composite starts the week on the rise while U.S. markets fall

TORONTO — Canada's main stock index jumped two per cent Tuesday as it caught up to a Monday market rally, while U.S. markets were down. The S&P/TSX composite index rose 549.65 points to 27,570.08 in broad gains after being closed Monday for the August long weekend. In New York, the Dow Jones industrial average was down 61.90 points to 44,111.74. The S&P 500 index was down 30.75 points at 6,299.19, while the Nasdaq composite was down 137.03 points at 20,916.55. The Canadian dollar traded for 72.54 cents US compared with 72.48 cents US on Friday. The September crude oil contract was down US$1.13 at US$65.16 per barrel. The December gold contract was up US$8.30 at US$3,434.70 an ounce. This report by The Canadian Press was first published Aug. 5, 2025. The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store